Entrada Therapeutics | Financial Information

SEC Filings

SEC Filings
Filing date	Form	Description	Filing Group	View
Apr 17, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Other	View HTML 0001950047-23-000148.pdf 0001950047-23-000148.rtf
Apr 04, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001689375-23-000023.pdf 0001689375-23-000023.rtf 0001689375-23-000023.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 04, 2023	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001689375-23-000024.pdf 0001689375-23-000024.rtf 0001689375-23-000024.xls
Apr 04, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001689375-23-000025.pdf 0001689375-23-000025.rtf 0001689375-23-000025.xls
Mar 29, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001689375-23-000020.pdf 0001689375-23-000020.rtf 0001689375-23-000020.xls